With systemic increases of ET-1 resulting in significant vasoconstriction of ocular vessels, and subsequent reduction in optic-nerve head perfusion, the observed increases in respiratory diseases, COPD and OSA, may pose a risk to the ocular system of individuals. Here, EDN1 is linked to obstructive sleep apnea syndrome.